← Back to Search

Procedure

Preventative Surgery for Contracture

N/A
Recruiting
Led By Sanjeev Kakar, M.D.
Research Sponsored by Mayo Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Failed non-operative treatment or elected surgical treatment
Clinical diagnosis of trigger finger with co-existing pretendinous cord
Must not have
Age less than 18 years
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, up to 1 year
Awards & highlights
No Placebo-Only Group

Summary

This trial is investigating a new surgical technique to help those with trigger finger and a pre-existing Dupuytren's cord minimize potential complications like scarring and discomfort after surgery.

Who is the study for?
This trial is for adults with trigger finger and a condition called Dupuytren's Contracture, who haven't had success with non-surgical treatments and have chosen to undergo surgery.
What is being tested?
The study tests a surgical technique that removes or manipulates the pretendinous cord during trigger finger surgery, aiming to reduce scarring and improve recovery.
What are the potential side effects?
Potential side effects may include discomfort, difficulty moving the affected fingers or hand, thickened scars at the surgery site, and other complications related to hand surgeries.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
Non-surgical treatments didn't work for me or I chose surgery.
Select...
I have been diagnosed with trigger finger and have a cord in my palm.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I am under 18 years old.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, up to 1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, up to 1 year for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in Scar Progression as measured by the Patient and Observer Scar Assessment Scale
Change in Scar Progression as measured by the Vancouver Scar Scale

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Active Control
Group I: Division/manipulation of the cordActive Control1 Intervention
patients will undergo either a targeted palmar fasciectomy procedure in which the involved Dupuytren's fascia will be incised.
Group II: Pretendinous cord excisionActive Control1 Intervention
Patients will undergo either a targeted palmar fasciectomy procedure in which the involved Dupuytren's fascia will be excised

Find a Location

Who is running the clinical trial?

Mayo ClinicLead Sponsor
3,353 Previous Clinical Trials
3,060,969 Total Patients Enrolled
Sanjeev Kakar, M.D.Principal InvestigatorMayo Clinic
Sanjeev Kakar, MDPrincipal InvestigatorMayo Clinic

Media Library

Division/manipulation of the cord (Procedure) Clinical Trial Eligibility Overview. Trial Name: NCT03155854 — N/A
Dupuytren's Contracture Research Study Groups: Division/manipulation of the cord, Pretendinous cord excision
Dupuytren's Contracture Clinical Trial 2023: Division/manipulation of the cord Highlights & Side Effects. Trial Name: NCT03155854 — N/A
Division/manipulation of the cord (Procedure) 2023 Treatment Timeline for Medical Study. Trial Name: NCT03155854 — N/A
~5 spots leftby Dec 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top